Metabolic Syndrome, Gastric Cancer Mortality and Competing Risk Survival Analysis

EBioMedicine - Netherlands
doi 10.1016/j.ebiom.2016.12.015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Juvenile Survival, Competing Risks, and Spatial Variation in Mortality Risk of a Marine Apex Predator

Journal of Applied Ecology
Ecology
2018English

Association Between Metabolic Syndrome and the Incidence of Gastric Cancer: A Meta-Analysis of Cohort Studies

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Metabolic Syndrome: Risk Factor Distribution and 18-Year Mortality in the Multiple Risk Factor Intervention Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2006English

Ramucirumab Extends Gastric Cancer Survival

Cancer Discovery
Oncology
2014English

Competing Risk Nomogram to Predict Cancer‑specific Survival in Esophageal Cancer During the Intensity‑modulated Radiation Therapy Era: A Single Institute Analysis

Oncology Letters
Cancer ResearchOncology
2020English

Metabolic Syndrome and Risk of Psoriasis

British Journal of Dermatology
DermatologyMedicine
2019English

Competing Risk Nomogram Predicting Initial Loco-Regional Recurrence in Gastric Cancer Patients After D2 Gastrectomy

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2019English

Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk: The Framingham Heart Study

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2007English

A Joint Longitudinal and Survival Model for Dynamic Treatment Regimes in Presence of Competing Risk Analysis

Clinical Epidemiology and Global Health
EpidemiologyPublic HealthMicrobiologyEnvironmentalInfectious DiseasesOccupational Health
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy